# FDA Inspection 1276115 - NACS Inc. - June 26, 2025

Source: https://www.keypedia.com/records/fda_inspections/nacs-inc/ee220642-9669-4a7f-9451-a50504a7147b
Source feed: FDA_Inspections

> FDA Inspection 1276115 for NACS Inc. on June 26, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276115
- Company Name: NACS Inc.
- Inspection Date: 2025-06-26
- Product Type: Human Drugs
- Office Name: Minneapolis District Office

## Related Documents

- [FDA Inspection 1164253 - 2022-02-10](https://www.keypedia.com/records/fda_inspections/nacs-inc/8108ba15-ee66-4a01-bdfc-6f4ad654a229)
- [FDA Inspection 1164253 - 2022-02-10](https://www.keypedia.com/records/fda_inspections/nacs-inc/0099a114-3312-4031-bf03-bbd872be5f30)
- [FDA Inspection 1026493 - 2017-08-22](https://www.keypedia.com/records/fda_inspections/nacs-inc/d3c0c0c3-4174-4fef-8845-7146a3c5960b)

Company: https://www.keypedia.com/companies/nacs-inc/0023f761-1665-4f8d-af31-324ab2da5b59

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d